Amyloidosis trials in Japan

3 of 13 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

  Where

  Bunkyō City, Kumamoto, Kurume, Matsumoto, Sendai, Shinjuku, Suita, Tsukuba, Ube, Yufu

  Age

  18 years and over

  People

  2,000 worldwide

  Run by

  Alnylam Pharmaceuticals

  See details and how to joinNCT07358078
• No phaseTaking people
  OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

  Where

  Tokyo

  People

  52,121 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06355934
• No phaseTaking people
  International Cardiac Amyloidosis Registry

  Where

  Sagamihara

  Age

  18 years and over

  People

  300 worldwide

  Run by

  Leiden University Medical Center

  See details and how to joinNCT06894290